-
design novel immunotherapies to prevent relapse in acute myeloid leukemia (AML), an aggressive and common form of hematological cancer. The most promising immunotherapeutic strategies will be tested in
-
environment, actively embracing diversity. Our team is a core member of the Microbial Systems Technology Centre of Excellence, the Enviromics valorization consortium, the BlueApp innovation hub
Searches related to Design
Enter an email to receive alerts for Design positions in postdoctoral